Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.
about
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degenerationDefining response to anti-VEGF therapies in neovascular AMDHigh-precision, non-invasive anti-microvascular approach via concurrent ultrasound and laser irradiation.Evaluation of circulating miRNAs in wet age-related macular degeneration.Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degenerationA delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.Risk factors of a reduced response to ranibizumab treatment for neovascular age-related macular degeneration--evaluation in a clinical setting.Blood flow velocity measured using the Retinal Function Imager predicts successful ranibizumab treatment in neovascular age-related macular degeneration: early prospective cohort studySwitching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis.Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.A Revised Hemodynamic Theory of Age-Related Macular Degeneration.Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation.Choose the right treatment for the right patientsSwitch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results.Protective Effect of Combined Caffeic Acid Phenethyl Ester and Bevacizumab Against Hydrogen Peroxide-Induced Oxidative Stress in Human RPE Cells.Efficacy of vitrectomy and inner limiting membrane peeling in age-related macular degeneration resistant to anti-vascular endothelial growth factor therapy, with vitreomacular traction or epiretinal membrane.Clinical pharmacology of intravitreal anti-VEGF drugs.Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
P2860
Q26771522-82E08FB0-46AA-4814-A473-C396AE7D8248Q26996510-25E84AF6-EBBF-4275-8589-84564DCBDDC7Q30365660-9D8F7F8C-7839-4445-9890-2DF5879C89F4Q33964372-F9BDF3C4-FF0F-45BD-A4DE-FEBDB3E3BEAEQ34092569-A8ADE1C6-3738-4699-A5E2-8E5FC8F49927Q34815427-5E820245-22D9-4DED-A472-08A20B7DB7A7Q35073805-731F6D16-E6C6-4132-BA78-DB0841D5E85DQ35599030-4DA56985-DFDF-465E-B6ED-CAAA99622197Q37582768-FAA3642D-E8A9-4BD4-9BD6-0E852782D49BQ38219895-3334F088-78E7-46DB-A2B5-5A79787E06ACQ38898742-D0585163-9B53-4B01-844A-C0C27D08DD44Q41950821-2A7F072D-B2A9-462D-941B-1B1DA26F05D1Q42359933-51312660-9531-4B40-BD8F-68AD7F56065EQ46048523-BBB9FE91-32E5-4A44-8016-5FCA65FD60BDQ47762178-4D5E5863-47A6-4148-B80F-EDFC8A328551Q47863735-36850726-08C4-4636-9499-AD7017755EA9Q48109878-17738FD9-29D2-44D0-A952-1B8DF11FA08CQ48276388-BFA9EEC6-FC3F-4D76-A117-15E928FFC585Q58694356-FC44D23B-B9BF-4856-8571-066FAF71415D
P2860
Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Non-responders to treatment wi ...... -related macular degeneration.
@ast
Non-responders to treatment wi ...... -related macular degeneration.
@en
Non-responders to treatment wi ...... -related macular degeneration.
@nl
type
label
Non-responders to treatment wi ...... -related macular degeneration.
@ast
Non-responders to treatment wi ...... -related macular degeneration.
@en
Non-responders to treatment wi ...... -related macular degeneration.
@nl
prefLabel
Non-responders to treatment wi ...... -related macular degeneration.
@ast
Non-responders to treatment wi ...... -related macular degeneration.
@en
Non-responders to treatment wi ...... -related macular degeneration.
@nl
P2093
P2860
P1476
Non-responders to treatment wi ...... -related macular degeneration.
@en
P2093
Carl Glittenberg
Ilse Krebs
Irene Steiner
Siamak Ansari-Shahrezaei
Stefan Hagen
Susanne Binder
P2860
P304
P356
10.1136/BJOPHTHALMOL-2013-303513
P407
P577
2013-08-21T00:00:00Z